IP Verse

Method For Producing Rna Molecule Compositions - EP3319622

The patent EP3319622 was granted to Curevac on Feb 12, 2020. The application was originally filed on Dec 22, 2016 under application number EP16826337A. The patent is currently recorded with a legal status of "Revoked".

EP3319622

CUREVAC
Application Number
EP16826337A
Filing Date
Dec 22, 2016
Status
Revoked
Mar 31, 2023
Grant Date
Feb 12, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECH RNA PHARMACEUTICALSNov 12, 2020THOMANN -

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
EXAMINATIONEP1083232
INTERNATIONAL-SEARCH-REPORTWO2015024669
OPPOSITIONWO2015135558

Non-Patent Literature (NPL) Citations (15) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
INTERNATIONAL-SEARCH-REPORT- THOMAS KRAMPS ET AL, "Messenger RNA-based vaccines: progress, challenges, applications", WILEY INTERDISCIPLINARY REVIEWS: RNA, (20130701), vol. 4, doi:10.1002/wrna.1189, ISSN 1757-7004, pages 737 - 749, XP055180522 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- GEERTRUI TAVERNIER ET AL, "mRNA as gene therapeutic: How to control protein expression", JOURNAL OF CONTROLLED RELEASE, (20110301), vol. 150, no. 3, doi:10.1016/j.jconrel.2010.10.020, ISSN 0168-3659, pages 238 - 247, XP055068617 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BENJAMIN PETSCH ET AL, "Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection", NATURE BIOTECHNOLOGY, (20120101), vol. 30, no. 12, doi:10.1038/nbt.2436, ISSN 1087-0156, pages 1210 - 1216, XP055051005 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- SUSAN BENNETT ET AL, "Rapid Simultaneous Detection of Enterovirus and Parechovirus RNAs in Clinical Samples by One-Step Real-Time Reverse Transcription-PCR Assay", JOURNAL OF CLINICAL MICROBIOLOGY, US, (20110701), vol. 49, no. 7, doi:10.1128/JCM.02445-10, ISSN 0095-1137, pages 2620 - 2624, XP055235243 [X] 1,2,16,19,23-26 * page 2621, column 1, paragraph 2 - page 2621, column 2, paragraph 1 * * page 2623, column 1, paragraph 2 * [Y] 3-15,17,18,20-22,27-29
INTERNATIONAL-SEARCH-REPORT- HU X ET AL, Simultaneously typing nine serotypes of enteroviruses associated with hand, foot, and mouth disease by a GeXP analyzer-based multiplex reverse transcription-PCR assay, JOURNAL OF CLINICAL MICROBIOLOGY 2012 AMERICAN SOCIETY FOR MICROBIOLOGY USA, VOL. 50, NR. 2, PAGE(S) 288 - 293, (201202), ISSN 0095-1137, XP002755277 [A] 1-39 * page 290, column 1, paragraph l - page 290, column 2, paragraph 1; figure 3 *
INTERNATIONAL-SEARCH-REPORT- JIN LI ET AL, "The development of a GeXP-based multiplex reverse transcription-PCR assay for simultaneous detection of sixteen human respiratory virus types/subtypes", BMC INFECTIOUS DISEASES, BIOMED CENTRAL, LONDON, GB, (20120814), vol. 12, no. 1, doi:10.1186/1471-2334-12-189, ISSN 1471-2334, pages 1 - 8, XP021106921 [X] 1,2,16,19,23-26 * page 2, column 1, paragraph l - page 5, column 1, paragraph 3; table 2 * * page 7, column 2, paragraph 1 * [Y] 3-15,17,18,20-22,27-29
INTERNATIONAL-SEARCH-REPORT- PASCOLO S, "Vaccination with messenger RNA", METHODS IN MOLECULAR MEDICINE, HUMANA PRESS, TOTOWA, NJ, US, (20060101), ISSN 1543-1894, pages 23 - 40, XP009117840 [A] 1-39 * the whole document *
INTERNATIONAL-SEARCH-REPORT- ULMER J B ET AL, "Vaccines 'on demand': Science fiction or a future reality", EXPERT OPINION ON DRUG DISCOVERY, INFORMA HEALTHCARE, LONDON, GB, (20150201), vol. 10, no. 2, doi:10.1517/17460441.2015.996128, ISSN 1746-0441, pages 101 - 106, XP008175781 [A] 1-39 * the whole document *
OPPOSITION- KAJITANI et al., "Determination of the promoter strength in the mixed transcription system: promoters of lactose, tryptophan and ribosomal protein L10 operons from Escherichia coli", Nucleic Acids Research, (19830000), vol. 11, pages 671 - 686-
OPPOSITION- KAJITANI et al., "Promoter Selectivity of Escherichia coli RNA Polymerase", Journal of Biological Chemistry, (19840000), vol. 259, pages 1951 - 1957-
OPPOSITION- LANGERT et al., "Functional Characteristics of the rrnD Promoters of Escherichia coli", Journal of Biological Chemistry, (19910000), vol. 266, pages 21608 - 21615, XP055755655-
OPPOSITION- NOMURA et al., "Promoter selectivity of Escherichia coli RNA polymerase: alteration by fMet-tRNAfMet", Nucleic Acids Research, (19860000), vol. 14, pages 6857 - 6870, XP055755650-
OPPOSITION- SHIMADA et al., "The Whole Set of Constitutive Promoters Recognized by RNA Polymerase RpoD Holoenzyme of Escherichia coli", PLOS ONE, (20140000), vol. 9, pages e90447, 1 - 22, XP055755657-
OPPOSITION- WILSON et al., "A Template-Selective Inhibitor of In Vitro Transcription", Proc. Nat. Acad. Sci., (19690000), vol. 62, pages 514 - 520, XP055755644-
OPPOSITION- PETSCH et al., "Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection", Nature Biotechnology, vol. 30, (20120000), pages 1210 - 1216, 1-2, XP055051005

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents